AstraZeneca | Resultado Líquido



Net Income Alterar Data
AbbVie USD 938M 348M 2025-06
Alcon AG USD 350M 66M 2025-03
Almirall EUR 26.58M 4.98M 2025-06
Amgen USD 1.73B 1.1B 2025-03
argenx SE USD 245.36M 75.89M 2025-06
AstraZeneca USD 2.45B 466M 2025-06
Autolus Therapeutics Ltd -70161000 42.55M 2025-03
Bayer EUR 1.3B 1.63B 2025-03
Biogen USD 634.8M 394.3M 2025-06
Bristol-Myers Squibb USD 1.31B 1.15B 2025-06
Eli Lilly USD 5.66B 2.9B 2025-06
Fresenius EUR 229M 11M 2025-03
Fresenius Medical Care EUR 225M 74M 2025-06
Galapagos EUR -105748000 47.66M 2025-06
Genmab DKK 195M 3.65B 2025-03
Gilead Sciences USD 1.96B 645M 2025-06
GlaxoSmithKline GBP 1.44B 181M 2025-06
GRIFOLS EUR 117.06M 57.34M 2025-06
Haleon 231M 254M 2024-12
Hikma Pharmaceutical USD 133M 93M 2024-12
Lonza CHF 307M 22M 2024-12
Merck EUR 652M 83M 2025-06
Merck USD 4.43B 652M 2025-06
Novartis USD 4.02B 418M 2025-06
Orion EUR 82.5M 21.3M 2025-06
Pfizer USD 2.91B 58M 2025-06
Philips EUR 240M 165M 2025-06
Recordati EUR 91.08M 33.96M 2025-06
Regeneron Pharmaceuticals USD 1.39B 582.9M 2025-06
Roche Holding CHF 1.01B 2.12B 2024-12
Sanofi EUR 3.94B 2.07B 2025-06
UCB EUR 857M 649M 2024-12


AstraZeneca Resultado Líquido - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.